1-3 of 3
Gabrielle Melanie Siegers, PhD
Close
Sort by
Journal Articles

Novel Patient Derived Multiple Myeloma Model Reflects Sensitivity Towards Anticancer Treatment in Multiple Myeloma Patients

Julia B. Schueler, DVM, PhD, Dagmar Wider, Kerstin Klingner, Gabrielle Melanie Siegers, PhD, Annette M May, MD, Johannes M. Waldschmidt, MD, Alexander Keller, MD, Justus Duyster, MD, Ralph M. Waesch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2015) 126 (23): 3004.
https://doi.org/10.1182/blood.V126.23.3004.3004
Published: 2015
Journal Articles

Chronic Myeloid Leukemia Patients Undergoing Interferon Alpha Therapy Exhibit Normal Peripheral Blood Gamma Delta T Cells That May Be Expanded in Vitro to Generate Predominantly CD45RA-Positive Effector Memory Cells for Immunotherapy

Gabrielle Melanie Siegers, PhD, Anna Kreutzman, PhD, Mette Matilda Ilander, MSc, Satu Mustjoki, MD, PhD, Lynne Marie Postovit, PhD
Journal: Blood
Blood (2012) 120 (21): 3729.
https://doi.org/10.1182/blood.V120.21.3729.3729
Published: 2012
Journal Articles

Gamma Delta T Cells (GDTCs) to Eliminate Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia (CML) : A Pre-Clinical Model

Gabrielle Melanie Siegers, PhD, Bassim Malas Al-Beirouti, MD, Alister Mark Mathieson, MSc., Tania Cristina Felizardo, PhD, Simone Helke, Jeffrey A. Medin, PhD, Armand Keating, MD
Journal: Blood
Blood (2008) 112 (11): 574.
https://doi.org/10.1182/blood.V112.11.574.574
Published: 2008